Skip to content

Gallbladder-preserving cholecystolithotomy for treating choledocholithiasis and cholecystolithiasis through endoscopic retrograde cholangiopancreatography combined with shock wave lithotripsy

Gallbladder-preserving cholecystolithotomyfor treating choledocholithiasis and cholecystolithiasis through endoscopic retrograde cholangiopancreatography combined with extracorporeal shock wave lithotripsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060927
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholelithiasis

Interventions

Observation group:Endoscopic retrograde cholangiopancreatography combined with extracorporeal shock wave lithotripsy

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) 18-80 years old, no gender limitation; (2) Preoperative abdominal ultrasound, CT or MRCP imaging examination confirmed the presence of choledocholithiasis combined with cholecystolithiasis; (3) The shape of the gallbladder was normal, without or accompanied by mild chronic cholecystitis, and the thickness of the gallbladder wall was <=3mm; (4) The patient had a desire to preserve gallbladder.

Exclusion criteria

Exclusion criteria: (1) acute cholecystitis with gallbladder suppuration, perforation and gangrene, xanthogranulomatous cholecystitis; (2) chronic cholecystitis, uniform thickening of gallbladder wall more than 3mm, or uneven thickness of gallbladder wall; (3) gallbladder wall fibrosis, porcelain gallbladder; (4) gallbladder atrophy, disappearance of gallbladder cavity, or too small volume; (5) Cystic duct obstruction and Mirrizzi syndrome; (6) diffuse cystic adenomyosis; (7) segmental cystic adenomyosis, septum less than 5mm, and the proximal gallbladder cavity is too small or the distal gallbladder wall thickened more than 3mm; (8) Diffuse Rokitansky-Aschoffsinusstones (RASS); (9) Gallbladder malignant tumor; (10) History of biliary surgery; (11) Patients with biliary duct tumor; (12) combined with bile duct stenosis deformity; (13) coagulopathy (INR > 1.5, PT > 2 times the upper limit of the reference value) and hemorrhagic diseases; (14) Patients with severe heart failure, severe renal failure and severe shock; (15) Mentally abnormal or uncooperative; (16) Obstruction of upper digestive tract; (17) Pregnant and lactation women or women who do not exclude the possibility of pregnancy.

Design outcomes

Primary

MeasureTime frame
technical success rate;clinical success rate;incidence of complications;recurrence rate of gallstone;

Countries

China

Contacts

Public ContactChen Youxiang
chenyx102@126.com13879169980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026